Clinical Trials List
2025-07-01 - 2027-12-31
Phase III
Recruiting4
ICD-10E78.4
Other hyperlipidemia
ICD-10E78.5
Hyperlipidemia, unspecified
ICD-9272.4
Other and unspecified hyperlipidemia
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 蔡依霖 Division of Cardiovascular Diseases
- Chern-En Chiang Division of Cardiovascular Diseases
- 張俊欽 Division of Cardiovascular Diseases
- 張皓智 Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
- 蔡泉財 Division of Cardiovascular Diseases
- 黃偉杰 Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 朱志生 Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 卓士傑 Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
- Wei-Chung Tsai Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張恬君 Division of Endocrinology
- 嚴愛文 Division of Endocrinology
- SUNG-CHUN TANG Division of Endocrinology
- HUNG-JU LIN Division of Endocrinology
- MAO-HSIN LIN Division of Endocrinology
- YEN-HUNG LIN Division of Endocrinology
- 呂金盈 Division of Endocrinology
- 林家宏 Division of Endocrinology
- 林志弘 Division of Endocrinology
- 吳婉禎 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 鄭諭聰 Division of Endocrinology
- 傅家保 Division of Endocrinology
- Tsun-Jui Liu Division of Endocrinology
- 蔡易婷 Division of Endocrinology
- 張之昀 Division of Endocrinology
- WEI-WEN LIN Division of Endocrinology
- 梁凱偉 Division of Endocrinology
- 李佳霖 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
405 participants